troc, using viruses to stimulate the immune (dendritic) cells is something everyone tries since several decades ago but not that fruitful; just a hit and miss kind of probability of success. They can't infringe DcVaxL concept and all these experts in big schools like Harvard and Duke are trying with the viruses knowing immunotherapy is the solution. I think we are the best in the space addressing all 100% of the tumor proteins and we have a patent fortress to protect the turf. DcVax is going to be a medical school text book science in the near future, imo.
News 
Market Data 
Discover 
